ABVX — ABIVAX SA AMERICAN DEPOSITARY SHARES (Healthcare >> Biotechnology)
ABVX FAQ
What is ABVX's ROE?
ABIVAX SA AMERICAN DEPOSITARY SHARES reports a Return on Equity (ROE) of -125.22%.
What is ABVX's dividend yield?
ABIVAX SA AMERICAN DEPOSITARY SHARES offers a dividend yield of 0.00%.
What is ABVX's Deepscope Quality Score?
Deepscope rates ABVX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ABVX?
Deepscope's AI Timing Score for ABVX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ABVX belong to?
ABIVAX SA AMERICAN DEPOSITARY SHARES is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 90.15
Price
17.65
(24.34%)
Day Change
|
|
|---|
ABVX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 31) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...
| Yếu tố Chất lượng |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 71 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 90.15 |
| PBV / Sector |
13.45 / 4.48
|
| Earning Per Share | -8.39 |
| PE / Sector |
N/A / 16.68
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
211.91 M
GREAT
|
| Average 1W Daily Value |
474.43 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
43% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-04 09:23:57 |
| Symbol | ABVX |
| Name | ABIVAX SA AMERICAN DEPOSITARY SHARES |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 79.69 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 5,777.85 / 8,483.11 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 7-11 Boulevard Haussmann, Paris, France, 75009
Phone: 33 1 53 83 09 63
Website: https://www.abivax.com
Employees: 80
Sector: Healthcare >> Biotechnology
Description: ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google